Extrahepatic complement biosynthesis: Where, when and why?

Clinical and Experimental Immunology

Volumn 107, Issue 1, 1997, Pages 1-7

  Morgan, B P ^a   Gasque, P ^a  

^a CARDIFF UNIVERSITY   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

COMPLEMENT;

ADIPOSE TISSUE; BIOSYNTHESIS; BRAIN; COMPLEMENT ACTIVATION; HOMEOSTASIS; HOST RESISTANCE; HUMAN; KIDNEY; LIVER; NONHUMAN; PRIORITY JOURNAL; PROTEIN SYNTHESIS; REVIEW;

EID: 0031015026     PISSN: 00099104     EISSN: None     Source Type: Journal    
DOI: 10.1046/j.1365-2249.1997.d01-890.x     Document Type: Review

References (103)

1. Alper CA, Johnson AM, Birtch AG, Moore RD. Human C3: evidence for the liver as the primary site of synthesis. Science 1969; 163:286-8.
2. Morris KM, Aden DP, Knowles BB, Colten HR. Complement biosynthesis by the human hepatoma derived cell line HepG2. J Clin Invest 1982; 70:906-13.
3. Manthei U, Strunk RC, Giclas PC. Acute local inflammation alters synthesis, distribution and catabolism of the third component of complement (C3) in rabbits. J Clin Invest 1984; 74:424-33.
4. Giclas PC, Strunk RC, Manthei U. The acute phase response of C3, C5, ceruloplasmin and C-reactive protein induced by turpentine pleurisy in the rabbit. Am J Pathol 1985; 120:146-56.
5. Tenner AJ, Volkin DB. Complement subcomponent C1q secreted by cultured human monocytes has subunit structure identical with that of serum C1q. Biochem J 1986; 233:451-8.
6. Gulati P, Lemercier C, Guc D, Lappin D, Whaley K. Regulation of the synthesis of C1 subcomponents and C1-inhibitor. Behring Inst Mitt 1993; 93:196-203.
7. Choy LN, Rosen BS, Spiegelman BM. Adipsin and an endogenous pathway of complement from adipose cells. J Biol Chem 1992; 267:12736-41.
8. White RT, Damm D, Hancock N, Rosen BS, Lowell BB, Usher P, Flier JS, Spiegelman BM. Human adipsin is identical to complement factor D and is expressed at high levels in adipose tissue. J Biol Chem 1992; 267:9210-3.
9. Maves KK, Weiler JM. Properdin: approaching four decades of research. Immunol Res 1993; 12:233-43.
10. Wurzner R, Joysey VC, Lachmann PJ. Complement component C7: assessment of in vivo synthesis after liver transplantation reveals that hepatocytes do not synthesise the majority of human C7. J Immunol 1994; 152:4624-9.
11. Hogasen AKM, Wurzner R, Abrahamsen TG, Dierich MP. Human polymorphonuclear leukocytes store large amounts of terminal complement component C7 and C6, which may be released on stimulation. J Immunol 1995; 154:4734-40.
12. McPhaden AR, Whaley K. Complement biosynthesis by mononuclear phagocytes. Immunol Res 1993; 12:213-32.
13. Hetland G, Johnson E, Falk R, Eskeland T. Synthesis of complement components C5, C6, C7, C8 and C9 in vitro by human monocytes and assembly of the terminal complement complex. Scand J Immunol 1986; 24:421-8.
14. Colten HR, Strunk RC. Synthesis of complement components in liver and at extrahepatic sites. In: Whaley K, Loos M, Weiler JM, eds. Complement in health and disease. Immunology and Medicine series, 20. Dordrecht: Kluver Academic Publishers. 1993:127-58.
15. Volanakis JE. Transcriptional regulation of complement genes. Ann Rev Immunol 1995; 13:277-305.
16. Levi-Strauss M, Mallat M. Primary cultures of murine astrocytes produce C3 and factor B, two components of the alternative pathway of complement activation. J Immunol 1987; 139:2361-6.
17. Barnum SR. Biosynthesis and regulation of complement by cells of the central nervous system. Complement Today 1993; 1:76-95.
18. Gasque P, Julen N, Ischenko AM, Picot C, Mauger C, Chauzy C, Ripoche J, Fontaine M. Expression of complement components of the alternative pathway by glioma cell lines. J Immunol 1992; 149:1381-7.
19. Gasque P, Ischenko A, Legoedec J, Mauger C, Schouft MT, Fontaine M. Expression of the complement classical pathway by human glioma in culture. J Biol Chem 1993; 268:25068-74.
20. Gasque P, Fontaine M, Morgan BP. Complement expression in human brain: biosynthesis of terminal pathway components and regulators in human glial cells and cell lines. J Immunol 1995; 154:4726-33.
21. Gasque P, Morgan BP. Complement regulatory protein expression by a human oligodendrocyte cell line; cytokine regulation and comparison with astrocytes. Immunology 1996; in press.
22. Walker DG, Kim SU, McGeer PL. Complement and cytokine gene expression in cultured microglia derived from postmortem human brains. J Neurosci Res 1995; 40:478-93.
23. Singhrao SK, Neal JW, Gasque P, Morgan BP, Newman GR. Role of complement in the aetiology of Pick's disease? J Neuropathol Exp Neurol 1996; 55:578-93.
24. Svensson M, Aldskogius H. Evidence for activation of the complement cascade in the hypoglossal nucleus following peripheral nerve injury. J Neuroimmunol 1992; 40:99-110.
25. Pasinetti GM, Johnson SA, Rozovsky I et al. Complement C1qB and C4 mRNAs responses to lesioning in rat brain. Exp Neurol 1992; 118:117-25.
26. Piddlesden SJ, Morgan BP. Killing of rat glial cells by complement: deficiency of the rat analogue of CD59 is the cause of oligodendrocyte susceptibility to lysis. J Neuroimmunol 1993; 48:169-76.
27. Gasque P, Thomas A, Fontaine M, Morgan BP. Complement activation on human neuroblastoma cell lines in vitro: route of activation and expression of functional complement regulatory proteins. J Neuroimmunol 1996; 66:29-40.
28. Gasque P, Chan P, Mauger C, Schouft M-T, Dierich MP, Morgan BP, Fontaine M. Expression of complement receptor 2 (CR2, CD21), the receptor for Epstein Barr virus and complement C3d, on human brain cells. J Immunol 1996; 156:2247-55.
29. Ischenko A, Gasque P, Andreev, S, Sumereau E, Lamacz M, Vaudry H, Fontaine M. Characterization of a complement C3a receptor (C3aR) on astrocytes. J Neuroimmunol 1994; 54:1-9.
30. Gasque P, Chan P, Fontaine M, Ischenko A, Lamacz M, Götze O, Morgan BP. Identification and characterisation of the complement C5a anaphylatoxin receptor on human astrocytes relevance to inflammation in the brain. J Immunol 1995; 155:4882-9.
31. Gasque P, Singhrao SK, Neal JW, Götze O, Morgan BP. Expression of the receptor for complement C5a (CD88) is upregulated on reactive astrocytes, microglia and endothelial cells in inflamed human CNS. Am J Pathol 1996; in press.
32. Schifferli JA, Ng YC, Peters DK. The role of complement and its receptor in the elimination of immune complexes. N Engl J Med 1986; 315:488-95.
33. Passwell J, Schreiner GF, Nonaka M, Beuscher HU, Colten HR. Local extrahepatic expression of complement genes C3, factor B, C2 and C4 is increased in murine lupus nephritis. J Clin Invest 1988; 82:1676-84.
34. Sacks SH, Zhou W, Campbell RD, Martin J. C3 and C4 gene-expression and interferon-γ-mediated regulation in human glomerular mesangial cells. Clin Exp Immunol 1993; 93:411-7.
35. Sacks SH, Zhou W, Pani A, Campbell RD, Martin J. Complement C3 gene expression and regulation in human glomerular epithelial cells. Immunology 1993; 79:348-54.
36. Zhou W, Campbell RD, Martin J, Sacks SH. Interferon-γ regulation of C4 gene expression in cultured human glomerular epithelial cells. Eur J Immunol 1993; 23:2477-81.
37. Welch TR, Beischel LS, Witte DP. Differential expression of complement C3 and C4 in the human kidney. J Clin Invest 1993; 92:1451-8.
38. Sacks SH, Zhou W, Andrews PA, Hartley B. Endogenous complement C3 synthesis in immune complex nephritis. Lancet 1993; 342:1273-4.
39. Andrews PA, Finn JE, Lloyd CM, Zhou W, Mathieson PW, Sacks SH. Expression and tissue localisation of donor specific complement C3 synthesised in human renal allografts. Eur J Immunol 1995; 25:1087-93.
40. Morgan BP. Complement and renal disease. In: Complement: clinical aspects and relevance to disease. London: Academic Press, 1990:112-29.
41. Andrews PA, Zhou W, Sacks SH. Tissue synthesis of complement as an immune regulator. Mol Med Today 1995; 1:202-7.
42. Brauer RB, Lam TT, Wang D, Horwitz LR, Hess AD, Klein AS, Sanfilippo F, Baldwin WM III. Extrahepatic synthesis of C6 in the rat is sufficient for complement-mediated rejection of a guinea pig cardiac xenograft. Transplantation 1995; 59:1073-6.
43. Platt KA, Claffey KP, Wilkinson WO, Spiegelman BM, Ross SR. Independent regulation of adipose tissue specificity and obesity response of the adipsin promoter in transgenic mice. J Biol Chem 1994; 269:28558-62.
44. Baldo A, Sniderman AD, StLuce S et al. The adipsin-acylation stimulating protein system and regulation of intracellular triglyceride synthesis. J Clin Invest 1993; 92:1543-7.
45. Sniderman AD, Cianflone KM. The adipsin-ASP pathway and regulation of adipocyte function, Ann Med 1994; 26:388-93.
46. Cianflone K, Roncari DA, Maslowska M, Baldo A, Forden J, Sniderman AD. Adipsin/acylation stimulating protein system in human adipocytes: regulation of triacylglycerol synthesis. Biochemistry 1994; 33:9489-95.
47. Baldo A, Sniderman AD, StLuce S, Zhang XJ, Cianflone K. Signal transduction pathway of acylation stimulating protein: involvement of protein kinase C. J Lipid Res 1995; 36:1415-26.
48. Cianflone K, Kalant D, Marliss EB, Gougeon R, Sniderman AD. Response of plasma ASP to a prolonged fast. Int J Obesity Rel Met Dis 1995; 19:604-9.
49. Mathieson PW, Wurzner R, Oliviera DBG, Lachmann PJ, Peters DK. Complement-mediated adipocyte lysis by nephritic factor sera. J Exp Med 1993; 177:1827-31.
50. Morgan BP. Complement membrane attack on nucleated cells: resistance, recovery and non-lethal effects. Biochem J 1989; 164:1-14.
51. McCoy R, Haviland DL, Molmenti EP, Ziambaras T, Wetsel RA, Perlmutter DH. N-formylpeptide and complement C5a receptors are expressed in liver cells and mediate hepatic acute phase gene regulation. J Exp Med 1995; 182:207-17.
52. Buchner RR, Hugli TE, Ember JA, Morgan EL. Expression of functional receptors for human C5a anaphylatoxin (CD88) on the human hepatocellular carcinoma cell line HepG2: stimulation of acute-phase protein-specific mRNA and protein synthesis by human C5a anaphylatoxin. J Immunol 1995; 155:308-15.
53. Frank MM. The mechanism by which microorganisms avoid complement attack. Curr Opin Immunol 1992; 4:14-19.
54. Jokiranta TS, Jokipii L, Meri S. Complement resistance of parasites. Scand J Immunol 1995; 42:9-20.
55. Cole FS, Colten HR. Complement biosynthesis: factors of the classical pathway. In: Rother K, Till GO, eds. The complement system. Berlin: Springer-Verlag, 1988:44-70.
56. Burger R. Complement biosynthesis: factors of the alternative pathway. In: Rother K, Till GO, eds. The complement system. Berlin: Springer-Verlag, 1988:70-80.
57. Ng SC, Sodetz JM. Biosynthesis of C8 by hepatocytes: differential expression and intracellular association of the α-γ and β subunits. J Immunol 1987; 139:3021-7.
58. Brauer RB, Baldwin III WM, Wang D, Horwitz R, Hess AD, Klein AS, Sanfilippo F. Hepatic and extrahepatic biosynthesis of complement factor C6 in the rat. J Immunol 1994; 153:3168-76.
59. Malhotra R. Collectin receptor (C1q receptor): structure and function. Behring Inst Mitt 1993; 93:254-61.
60. Bitter-Suermann D. The anaphylatoxins. In: Rother K, Till GO, eds. The complement system. Berlin: Springer-Verlag, 1988:367-95.
61. Gerard C, Gerard NP. C5a anaphylatoxin and its seven trans-membrane-segment receptor. Ann Rev Immunol 1994; 12:775-808.
62. Wetsel RA. Structure, function and cellular expression of complement anaphylatoxin receptors. Curr Opin Immunol 1995; 7:48-53.
63. Crass T, Raffetseder U, Martin U, Grove M, Klos A, Kohl J, Bautsch W. Expression cloning of the human C3a anaphylatoxin receptor (C3aR) from differentiated U-937 cells. Eur J Immunol 1996; 26:1944-50.
64. Pantazis P, Kalyanaraman VS, Bing DH. Synthesis of the third component of complement (C3) by lectin-activated and HTLV-infected human T cells. Mol Immunol 1990; 27:283-9.
65. Schwaeble W, Dippold WG, Schafer MKH et al. Properdin, a positive regulator of complement activation, is expressed in human T cell lines and peripheral blood T cells. J Immunol 1993; 151:2521-8.
66. Reed W, Roubey RAS, Dalzell JG, Matteucci BM, Myones BL, Hunt SW, Kolb WP, Ross GD. Synthesis of complement component C5 by human B and T lymphoblastoid cell lines. Immuno-genetics 1990; 31:145-51.
67. Tsoukas CD, Lambris JD. Expression of EBV/C3d receptors on T cells: biological significance. Immunol Today 1993; 14:56-59.
68. Tenner AJ. Functional aspects of the C1q receptors. Behring Inst Mitt 1993; 93:241-53.
69. Ahearn JM, Fearon DT. Structure and function of the complement receptors CR1 (CD35) and CR2 (CD21). Adv Immunol 1989; 46:183-219.
70. Lambris, JD. The chemistry, biology, and phylogeny of C3. In: Cruse JM, Lewis RE, eds. Complement today. Complement profiles. Basel: Karger, 1993; 1:16-45.
71. Whaley K. Biosynthesis of the complement components and the regulatory proteins of the alternative complement pathway by human peripheral blood monocytes. J Exp Med 1980; 151:501-6.
72. Bensa JC, Reboul JA, Colomb MG. Biosynthesis in vitro of complement subcomponents C1q. C1s and C1-inhibitor by resting and stimulated human monocytes. Biochem J 1983; 216:385-92.
73. Lappin DF, Whaley K. Interferon-induced transcriptional and post-transcriptional modulation of factor H and C4 binding protein synthesis in human monocytes. Biochem J 1990; 271:767-72.
74. Schmaier AH, Smith PM, Colman RW. Platelet C1 inhibitor, a secreted alpha-granule protein. J Clin Invest 1985; 75:242-50.
75. Tedesco F, Densen P, Villa MA, Presani G, Roncelli L, RossoDiSanSecondo VEM. Functional C8 associated with human platelets. Clin Exp Immunol 1986; 66:472-80.
76. Devine DV, Rosse WF. Regulation of the activity of platelet-bound C3 convertase of the alternative pathway of complement by platelet factor H. Proc Natl Acad Sci USA 1987; 84:5873-7.
77. Houle JJ, Leddy JP, Rosenfeld SI. Secretion of the terminal complement proteins C5-C9, by human platelets. Clin Immunol Immunopathol 1989; 50:385-93.
78. Botto M, Lissandrini D, Sorio C, Walport MJ. Biosynthesis and secretion of complement component (C3) by activated human polymorphonuclear leukocytes. J Immunol 1992; 149:1348-55.
79. Moffat GJ, Tack BF. Regulation of C4b-binding protein gene expression by the acute-phase mediators tumor necrosis factor-α, interleukin-6 and interleukin-1. Biochemistry 1992; 31:12376-84.
80. Schwaeble W, Schafer MKH, Petry F, Fink T, Knebel D, Weihe E, Loos M. Follicular dentritic cells, interdigitating cells, and cells of the monocyte-macrophage lineage are the C1q-producing sources in the spleen. Identification of specific cell types by in situ hybridization and immunohistochemical analysis. J Immunol 1995; 155:4971-8.
81. Al-Adnami MS, McGee JOD. C1q production and secretion by fibroblasts. Nature 1976; 263:145-6.
82. Katz Y, Strunk RC. Synthesis and regulation of complement protein factor H in human skin fibroblasts. J Immunol 1988; 141:559-63.
83. Katz Y, Strunk RC. Synthesis and regulation of C1 inhibitor in human skin fibroblasts. J Immunol 1989; 142:2041-5.
84. Garred P, Hetland G, Mollnes TE, Stoervold G. Synthesis of C3, C5, C6, C8 and C9 by human fibroblasts. Scand J Immunol 1990; 32:555-60.
85. Warren HB, Pantazis P, Davies PF. The third component of complement is transcribed and secreted by cultured human endothelial cells. Am J Pathol 1987; 129:9-13.
86. Ripoche J, Mitchell JA, Erdei A, Madin C, Moffat B, Mokoena T, Gordon S, Sim RB. Interferon gamma induces synthesis of complement alternative pathway proteins by human endothelial cells in culture. J Exp Med 1988; 167:1-14.
87. Brooimans RA, Hiemetra PS, van der Ark AAJ, Sim RB, van Es LA, Daha MR. Biosynthesis of complement factor H by human umbilical vein endothelial cells. Regulation by T cell growth factor and IFN-γ. J Immunol 1989; 142:2024-30.
88. Morris KM, Colten HR, Bing DH. The first component of complement: a quantitative comparison of its biosynthesis in culture by human epithelial and mesenchymal cellls. J Exp Med 1978; 148:1007-19.
89. Strunk RC, Eidler DM, Mason RJ. Pulmonary alveolar type II cells synthesize and secrete proteins of the classical and alternative complement pathways. J Clin Invest 1988; 81:1419-26.
90. Rothman BL, Merrow M, Bamba M, Kennedy T, Kreutzer DL. Biosynthesis of the third and fifth complement components by isolated human lung cells. Am Rev Respir Dis 1989; 139:212-20.
91. Rothman BL, Despins AW, Kreutzer DL. Cytokine regulation of C3 and C5 production by the human type II pneumocyte cell line, A549. J Immunol 1990; 145:592-8.
92. Katz Y, Revel M, Strunk RC. Interleukin 6 stimulates synthesis of complement proteins factor B and C3 in human skin fibroblasts. Eur J Immunol 1989; 19:983-8.
93. Dovezenski N, Billeta R, Gigli I. Expression and localization of proteins of the complement system in human skin. J Clin Invest 1992; 90:2000-12.
94. Basset-Seguin N, Caughman SW, Yancey KB. A-431 cells and human keratinocytes synthesize and secrete the third component of complement. J Invest Dermatol 1990; 95:621-5.
95. Andoh A, Fujiyama Y, Bamba T, Hosada S. Differential cytokine regulation of complement C3, C4 and factor B synthesis in human intestinal epithelial cell line Caco-2. J Immunol 1993; 151:4239-47.
96. Molmenti EP, Ziambaras T, Perlmutter DH. Evidence for an acute phase response in human intestinal epithelial cells. J Biol Chem 1993; 268:14116-24.
97. Legoedec J, Gasque P, Jeanne JF, Fontaine M. Expression of the complement alternative pathway by humaan myoblasts in vitro: biosynthesis of C3, factor B, factor H and factor I. Eur J Immunol 1995; 25:3460-6.
98. Gasque P, Morgan BP, Legoedec J, Chan P, Fontaine M. Human skeletal myoblasts spontaneously activate allogeneic complement but are resistant to killing. J Immunol 1996; 156:3402-11.
99. Ruddy S, Colten HR. Rheumatoid arthritis: biosynthesis of complement proteins by synovial tissues. N Engl J Med 1974; 290:1284-8.
100. Katz Y, Strunk RC. Synovial fibroblast-like cells synthesize seven proteins of the complement system. Arthritis Rheum 1988; 31:1365-70.
101. Guc D, Gulati P, Lemercier C, Lappin D, Birnie GD, Whaley K. Expression of the components and regulatory proteins of the alternative complement pathway and the membrane attack complex in normal and disease synovium. Rheumatol Int 1993; 13:139-46.
102. Gulati P, Guc D, Lemercier C, Lappin D, Whaley K. Expression of the components and regulatory proteins of the classical pathway of complement in normal and diseased synovium. Rheumatol Int 1994; 14:13-19.
103. Sundstrom SA, Komm BS, Ponce de Leon H, Yi Z, Teuscher C, Lyttle CR. Estrogen regulation of tissue-specific expression of complement C3. J Biol Chem 1989; 264:16941-7.